• Ruthenium Red: Redefining Ca2+ Transport Inhibition in Mecha

  2026-08-01

  Explore how Ruthenium Red, a premier Ca2+ transport inhibitor, uniquely advances mechanical stress and cytoskeleton-dependent autophagy research. This guide provides mechanistic insights, protocol parameters, and critical interpretation for cutting-edge calcium signaling studies.

• HyperPFU™ High-Fidelity DNA Polymerase: Practical PCR Guidan

  2026-07-31

  HyperPFU™ high-fidelity DNA polymerase addresses the persistent challenge of accurate PCR amplification of long, GC-rich, or otherwise difficult DNA templates. It is optimal for workflows requiring blunt-ended, high-fidelity PCR products, but should not be used for applications needing 3'-A overhangs or sticky ends.

• AMPK–SQSTM1 Feedback Enhances Dual Antioxidant Defense in Tu

  2026-07-31

  The referenced study uncovers a double-positive feedback loop between AMPK and SQSTM1/p62 under metabolic stress, enabling synergistic activation of AMPK and NFE2L2/NRF2 antioxidant pathways. These findings clarify the molecular basis for tumor adaptation, particularly in lung cancer with co-occurring STK11 and KEAP1 mutations, and suggest new avenues for targeted metabolic interventions.

• Ruthenium Red: Unveiling Mechanotransduction in Cytoskeleton

  2026-07-30

  This thought-leadership article explores how Ruthenium Red, a potent Ca2+ transport inhibitor from APExBIO, is revolutionizing cytoskeleton-dependent autophagy research under mechanical stress. Integrating mechanistic insights and strategic guidance, we bridge foundational calcium signaling research with the rapidly evolving landscape of mechanotransduction, providing actionable intelligence for translational researchers.

• Perospirone (SM-9018 Free Base): Applied Workflows in Schizo

  2026-07-30

  Perospirone (SM-9018 free base) bridges advanced neuropsychiatric disorder modeling with innovative cardiovascular assays, uniquely combining high-affinity receptor antagonism and Kv1.5 channel inhibition. This guide translates new mechanistic findings into actionable experimental protocols and troubleshooting strategies, empowering researchers to maximize data reliability and translational relevance.

• Structural Basis of ASCH Domain Proteins in N4-Acetylcytidin

  2026-07-29

  Meng et al. provide the first high-resolution structural analysis of ASCH domain-containing proteins involved in N4-Acetylcytidine (ac4C) metabolism. Their work clarifies the catalytic specificity of EcYqfB, revealing it acts on free ac4C nucleoside but not on RNA-incorporated modifications, refining the mechanistic understanding of nucleotide processing in RNA epigenetics research.

• BAPTA-AM (B4758): Technical Guide for Calcium Chelation Assa

  2026-07-29

  BAPTA-AM is a cell-permeable calcium chelator designed for precise and rapid modulation of intracellular Ca²⁺, making it suitable for assays targeting calcium signaling, apoptosis, and neuroprotection. It is not appropriate for workflows requiring magnesium selectivity or prolonged reagent stability due to its selectivity profile and solubility constraints. Researchers should strictly follow handling and control procedures to ensure reliable results.

• AMPK–SQSTM1 Feedback Synergizes Antioxidant Defense in Stres

  2026-07-28

  This study uncovers a double-positive feedback loop between AMPK and SQSTM1/p62, driving dual activation of AMPK and NFE2L2/NRF2 under metabolic stress. The findings elucidate how tumor cells coordinate antioxidant defense and metabolic adaptation, offering mechanistic insight into the significance of co-occurring STK11 and KEAP1 mutations in cancer.

• Dabigatran Etexilate: Oral Direct Thrombin Inhibitor for Str

  2026-07-28

  The reference study establishes dabigatran etexilate as the first oral direct thrombin inhibitor, demonstrating rapid, predictable anticoagulant effects without the frequent monitoring required by traditional agents. This innovation addresses major clinical challenges in stroke and venous thromboembolism prevention, especially for patients with atrial fibrillation.

• Rucaparib (AG-014699): Enhanced Protocols for DNA Repair Res

  2026-07-27

  Rucaparib (AG-014699) empowers precision in DNA repair, radiosensitization, and cancer model workflows, especially where alternative splicing or PTEN/ETS status dictates sensitivity. This guide decodes advanced protocols and troubleshooting strategies, integrating new findings in spliceosome acetylation to maximize research outcomes.

• ISRIB (trans-isomer) as a Precision Tool for Targeting ATF4-

  2026-07-27

  Explore how ISRIB (trans-isomer), a leading PERK inhibitor, enables precise modulation of ATF4-regulated pathways in liver fibrosis and beyond. This article uniquely bridges molecular mechanism with translational research, providing actionable insights for ER stress and apoptosis assays.

• D-Luciferin Potassium Salt: Precision Imaging and Assay Solu

  2026-07-26

  D-Luciferin (potassium salt) empowers researchers with unmatched sensitivity and workflow efficiency for both in vivo bioluminescence imaging and in vitro luciferase assays. Its water solubility and high purity streamline tumor and stem cell tracking, as well as high-throughput screening, making it indispensable for translational research.

• Deferiprone in Translational Research: Iron, Apoptosis, and

  2026-07-25

  This thought-leadership article illuminates how Deferiprone (3-hydroxy-1,2-dimethylpyridin-4-one), through precision iron modulation, is advancing the frontiers of translational research in cancer biology, metabolic reprogramming, and neurovascular protection. Integrating mechanistic findings from recent metabolomics studies and validated workflows, we provide strategic guidance for leveraging Deferiprone—sourced from APExBIO—for reproducible control of iron-dependent signaling, apoptosis induction, and experimental resilience.

• HDAC Inhibition Reverses EBV-Induced Plasticity in NPC Cells

  2026-07-24

  This study uncovers how Epstein-Barr virus (EBV) drives dedifferentiation and stem-like plasticity in nasopharyngeal carcinoma (NPC) through epigenetic repression of CEBPA. It demonstrates that HDAC inhibition can restore differentiation, offering a mechanistic basis for targeting cellular plasticity in solid tumors and informing future differentiation therapy strategies.

• DIDS: Advanced Assay Design and Translational Insights in Ch

  2026-07-24

  Explore the multifaceted role of DIDS (4,4'-Diisothiocyanostilbene-2,2'-disulfonic Acid) in channel modulation, neuroprotection, and cancer research. This article uniquely bridges mechanism, protocol, and translational impact—empowering advanced assay decisions.

14802 records 2/987 page Previous Next 12345 下5页 Last page